In a 22‑year‑old patient with Crohn’s disease in remission on adalimumab (Humira), mesalamine (Pentasa), and azathioprine who sustained a forearm fracture‑dislocation requiring surgery, how should the Crohn’s medications be managed perioperatively?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Perioperative Management of Crohn's Disease Medications for Urgent Orthopedic Surgery

Continue adalimumab, azathioprine, and mesalamine through the perioperative period without interruption for this urgent orthopedic surgery. 1

Key Management Principles

This is an urgent/emergent orthopedic procedure (fracture-dislocation requiring surgery), not elective IBD-related surgery, which fundamentally changes the risk-benefit calculation. The patient's Crohn's disease is in remission, making disease flare from medication withdrawal a real concern that outweighs theoretical surgical risks.

Adalimumab (Anti-TNF Therapy)

Do not stop adalimumab. The British Society of Gastroenterology guidelines specifically state that anti-TNF therapy discontinuation recommendations apply to "elective surgery" where cessation is "clinically appropriate" 1. For urgent/emergent procedures:

  • The 4-week pre-surgical cessation window recommended for adalimumab in elective IBD surgery is not applicable here 1
  • Evidence shows only a "small increase in risk of infectious complications" with anti-TNF therapy, which is less than the risk from corticosteroids 1
  • The 2023 ECCO guidelines and 2024 ECCO surgical guidelines both recommend against cessation of biologics prior to surgery, as current evidence suggests preoperative anti-TNF therapy does not significantly increase postoperative complications 2, 3
  • The PUCCINI trial (largest prospective study) showed no difference in infection rates between patients using biologics and those not using them 3

Azathioprine (Thiopurine)

Continue azathioprine without interruption. The evidence is clear:

  • "With one exception, the literature on the use of immunosuppressive therapy (thiopurines and methotrexate) leading up to surgery does not describe an association with an increased risk of postoperative complications" 1
  • Thiopurines are safe in the perioperative period and do not require cessation 1

Mesalamine (Pentasa)

Continue mesalamine. Aminosalicylates have no significant immunosuppressive effects and pose no perioperative risk. The FDA label explicitly states "Aminosalicylates and/or corticosteroids may be continued during treatment with HUMIRA" 4.

Practical Perioperative Considerations

Timing of Next Adalimumab Dose

  • If the patient is due for adalimumab around the time of surgery, do not delay the dose
  • Administer on schedule even if this falls within days of the procedure
  • The theoretical concern about wound healing is outweighed by the risk of disease flare in this remission patient

Postoperative Monitoring

  • Monitor surgical site for infection (standard surgical care)
  • Watch for signs of Crohn's flare (abdominal pain, diarrhea, weight loss)
  • Resume normal medication schedule immediately postoperatively
  • No need for "stress dose" steroids as patient is not on corticosteroids 1

Nutritional Optimization

  • Assess and correct any nutritional deficiencies (iron, vitamin D, B12) if time permits before surgery
  • Ensure adequate protein intake for wound healing
  • This is particularly important given the patient's IBD history 1

Critical Pitfalls to Avoid

  1. Do not extrapolate elective IBD surgery guidelines to urgent orthopedic procedures - The risk-benefit calculation is completely different
  2. Do not stop medications "to be safe" - This increases the risk of Crohn's flare, which would complicate postoperative recovery far more than continuing therapy
  3. Do not delay surgery to create a "drug-free window" - Fracture-dislocations require urgent surgical intervention; delaying for medication washout is inappropriate
  4. Do not confuse this with high-risk IBD surgery - This patient has no fistulae, no abscess, normal albumin (presumably), and is in remission - the classic high-risk features for IBD surgery complications are absent 1

Evidence Quality Note

The guidelines consistently distinguish between elective IBD-related surgery (where medication optimization may include cessation) and other surgical scenarios. The 2019 and 2025 BSG guidelines 1, 5, 1, 2023 ECCO perioperative review 2, and 2024 ECCO surgical guidelines 3 all support continuation of biologics and immunosuppressants when cessation is not "clinically appropriate" - which clearly applies to urgent orthopedic trauma surgery in a patient with quiescent disease.

References

Related Questions

What is the therapeutic trough level for adalimumab (adalimumab)?
Can Humira (adalimumab) cause fatigue after administration?
Can mesalamine and mercaptopurine be continued if a patient (pt) needs surgery?
What is the effect of Omalizumab (anti-IgE antibody) on Crohn's disease?
What is the first-line treatment for Crohn's disease (Crohn's disease) without an acute flare?
How should I manage allodynia caused by wearing woven silk underwear when there are no other symptoms?
How should I manage generalized clothing‑induced allodynia that resolves when I wear woven silk underwear?
What is the best anticoagulation option for an 85-year-old male patient with heparin-induced thrombocytopenia (HIT), weighing approximately 60 kg and having a serum creatinine of 2 mg/dL?
What alternative anticoagulant can be used if argatroban is unavailable for an 85‑year‑old man weighing about 60 kg with impaired renal function (serum creatinine 2 mg/dL)?
What is the recommended antibiotic regimen for treating pneumonia caused by gram‑positive cocci?
In a patient over 50 years old with new‑onset headache, scalp tenderness, jaw claudication, and elevated inflammatory markers suggestive of temporal (giant cell) arteritis, is an urgent ophthalmology consultation beneficial?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.